Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.

Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke as compared with aspirin alone when treatment is initiated early (≤24 hours) after an acute mild stroke. The effect of ...

Because of the trust you have with your patients, you are in a unique position to notice, evaluate, and act on neurologic and other conditions your patients experience. As you are interacting with ...